在慢性心力衰竭患者中停止循环利尿剂:一项回顾性研究
Gonçalo Silva1, Brenda Moura2, Emília Moreira3
1Faculty of Medicine, University of Porto, Portugal; CINTESIS@RISE, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal.
概括
在稳定的心力衰竭 (HF) 患者中停止循环利尿剂对许多人来说是安全的,只有少数恶化的事件. 在停止服用这些HF药物后,功能得到改善.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 循环利尿剂对于控制心力衰竭 (HF) 拥堵至关重要.
- 它们对HF预后的影响尚不清楚.
- 对于稳定的患者缺乏停止治疗的指导方针.
研究的目的:
- 为了评估停止循环利尿剂在外科患者的安全性和预后影响,与减少喷射分数的HF.
主要方法:
- 对停止使用循环利尿剂的HF门诊患者进行了回顾性队列研究.
- 收集的人口,临床和实验室数据.
- 在停止治疗后一年内监测到拥堵性事件.
主要成果:
- 在265名患者中,有129名患者停止了循环利尿剂的治疗.
- 在122名随访患者中,14.8%的患者经历了堵塞性事件,大多数需要重新启动尿剂.
- 只有2.5%的心力衰竭事件恶化.
- 停药后,功能显著改善.
结论:
- 循环利尿剂的停用在一组稳定的HF患者中似乎是安全的.
- 需要进一步的研究,因为结果不能被广泛推断.
相关概念视频
Heart Failure Drugs: Diuretics
363
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
363
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
420
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
420
Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
Antihypertensive Drugs: Potassium-Sparing Diuretics
512
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
512
Antihypertensive Drugs: Action of Diuretics
665
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
665
Heart Failure Drugs: Inotropic Agents
564
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
564


